![](/images/general/no_picture/200_user.png)
Ayub A Maye
Examiner (ID: 12823, Phone: (571)270-5037 , Office: P/3742 )
Most Active Art Unit | 3742 |
Art Unit(s) | 3742, 3761, 2436 |
Total Applications | 674 |
Issued Applications | 377 |
Pending Applications | 22 |
Abandoned Applications | 275 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13492861
[patent_doc_number] => 20180297973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Nitroalkene Trolox Derivatives and Methods of Use Thereof In The Treatment And Prevention of Inflammation Related Conditions
[patent_app_type] => utility
[patent_app_number] => 15/972518
[patent_app_country] => US
[patent_app_date] => 2018-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15972518
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/972518 | Nitroalkene Trolox Derivatives and Methods of Use Thereof In The Treatment And Prevention of Inflammation Related Conditions | May 6, 2018 | Abandoned |
Array
(
[id] => 14991143
[patent_doc_number] => 20190314529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => DYE ENHANCED VISUALIZATION OF CATARACT SURGERY
[patent_app_type] => utility
[patent_app_number] => 15/953310
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15953310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/953310 | Dye enhanced visualization of cataract surgery | Apr 12, 2018 | Issued |
Array
(
[id] => 13328351
[patent_doc_number] => 20180215713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => AMINOBENZAMIDE DERIVATIVES AS USEFUL AGENTS FOR CONTROLLING ANIMAL PARASITES
[patent_app_type] => utility
[patent_app_number] => 15/938900
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938900 | Aminobenzamide derivatives as useful agents for controlling animal parasites | Mar 27, 2018 | Issued |
Array
(
[id] => 13339533
[patent_doc_number] => 20180221306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF 5-HYDROXY-2-METHYLNAPHTHALENE-1,4-DIONE
[patent_app_type] => utility
[patent_app_number] => 15/922405
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15922405
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/922405 | PHARMACEUTICAL COMPOSITIONS OF 5-HYDROXY-2-METHYLNAPHTHALENE-1,4-DIONE | Mar 14, 2018 | Abandoned |
Array
(
[id] => 15586029
[patent_doc_number] => 20200069549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => TOPICAL FORMULATION FOR THE TREATMENT OF PIGMENTED SKIN
[patent_app_type] => utility
[patent_app_number] => 16/493314
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493314 | TOPICAL FORMULATION FOR THE TREATMENT OF PIGMENTED SKIN | Mar 13, 2018 | Abandoned |
Array
(
[id] => 17858477
[patent_doc_number] => 11439615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Lipoxin and lipoxin analogue mediated neuroprotection and treatments
[patent_app_type] => utility
[patent_app_number] => 16/492494
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 93
[patent_no_of_words] => 15936
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492494 | Lipoxin and lipoxin analogue mediated neuroprotection and treatments | Mar 8, 2018 | Issued |
Array
(
[id] => 14609603
[patent_doc_number] => 10357479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
[patent_app_type] => utility
[patent_app_number] => 15/915817
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7166
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915817
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915817 | Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats | Mar 7, 2018 | Issued |
Array
(
[id] => 18202334
[patent_doc_number] => 11584716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Production of arylpyrrol compounds in the presence of DIPEA base
[patent_app_type] => utility
[patent_app_number] => 16/492119
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 8534
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492119 | Production of arylpyrrol compounds in the presence of DIPEA base | Mar 4, 2018 | Issued |
Array
(
[id] => 17712242
[patent_doc_number] => 11376220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
[patent_app_type] => utility
[patent_app_number] => 15/912101
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6075
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15912101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/912101 | Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals | Mar 4, 2018 | Issued |
Array
(
[id] => 15239719
[patent_doc_number] => 20190374645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => ABSORPTION PROMOTER AND USE FOR SAME
[patent_app_type] => utility
[patent_app_number] => 16/489181
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489181 | Absorption promoter and use for same | Mar 1, 2018 | Issued |
Array
(
[id] => 16175544
[patent_doc_number] => 20200222512
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-07-16
[patent_title] => Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
[patent_app_type] => utility
[patent_app_number] => 15/905616
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905616
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/905616 | Topical ocular preparation of botulinum toxin for use in ocular surface disease | Feb 25, 2018 | Issued |
Array
(
[id] => 16175544
[patent_doc_number] => 20200222512
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-07-16
[patent_title] => Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
[patent_app_type] => utility
[patent_app_number] => 15/905616
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905616
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/905616 | Topical ocular preparation of botulinum toxin for use in ocular surface disease | Feb 25, 2018 | Issued |
Array
(
[id] => 14169245
[patent_doc_number] => 10258609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Therapeutic agent for dyslipidemia
[patent_app_type] => utility
[patent_app_number] => 15/904922
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6422
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15904922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/904922 | Therapeutic agent for dyslipidemia | Feb 25, 2018 | Issued |
Array
(
[id] => 12831673
[patent_doc_number] => 20180169063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => BENZOTHIOPHENE DERIVATIVES AND COMPOSITIONS THEREOF AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS
[patent_app_type] => utility
[patent_app_number] => 15/898561
[patent_app_country] => US
[patent_app_date] => 2018-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15898561
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/898561 | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders | Feb 16, 2018 | Issued |
Array
(
[id] => 16189439
[patent_doc_number] => 20200230288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => HYDROGEL USING, AS SUBSTRATE, HYALURONIC ACID DERIVATIVE MODIFIED WITH GALLOL GROUP AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/483146
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483146
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483146 | HYDROGEL USING, AS SUBSTRATE, HYALURONIC ACID DERIVATIVE MODIFIED WITH GALLOL GROUP AND USE THEREOF | Feb 1, 2018 | Abandoned |
Array
(
[id] => 12790498
[patent_doc_number] => 20180155335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => SALT AND CRYSTAL FORMS OF PLK-4 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/886104
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886104
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886104 | Salt and crystal forms of PLK-4 inhibitor | Jan 31, 2018 | Issued |
Array
(
[id] => 17726483
[patent_doc_number] => 11382848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Compounds reducing malodour perception and the use thereof
[patent_app_type] => utility
[patent_app_number] => 16/480331
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27747
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480331
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480331 | Compounds reducing malodour perception and the use thereof | Jan 29, 2018 | Issued |
Array
(
[id] => 13311203
[patent_doc_number] => 20180207138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => METHODS FOR THE TREATMENT OF TREMORS BY POSITIVE MODULATION OF SK CHANNELS
[patent_app_type] => utility
[patent_app_number] => 15/877918
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877918
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877918 | METHODS FOR THE TREATMENT OF TREMORS BY POSITIVE MODULATION OF SK CHANNELS | Jan 22, 2018 | Abandoned |
Array
(
[id] => 12746362
[patent_doc_number] => 20180140621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 15/877067
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877067
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877067 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING ARTHRITIS | Jan 21, 2018 | Abandoned |
Array
(
[id] => 16428231
[patent_doc_number] => 10828291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Decreasing expression level of proteasome subunit genes by treating a human subject with a nitroxide
[patent_app_type] => utility
[patent_app_number] => 15/877050
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18952
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877050
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877050 | Decreasing expression level of proteasome subunit genes by treating a human subject with a nitroxide | Jan 21, 2018 | Issued |